The distribution of parotid gland neoplasms in a veteran population

Objective: Salivary gland tumors account for 6%–8% of head and neck neoplasms with the parotid gland as the most common primary site. Pleomorphic adenomas (PA) are considered the most common benign parotid gland neoplasms, followed by Warthin tumors (WT). The goal of this study was to investigate th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adnan S. Hussaini, Navin R. Prasad, Edina Paal, Eshetu A. Tefera, Sonya Malekzadeh, Jessica H. Maxwell
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2021
Materias:
Acceso en línea:https://doaj.org/article/1ad2bf9bea2a4486911d37633b76cb39
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1ad2bf9bea2a4486911d37633b76cb39
record_format dspace
spelling oai:doaj.org-article:1ad2bf9bea2a4486911d37633b76cb392021-12-02T18:53:55ZThe distribution of parotid gland neoplasms in a veteran population2095-881110.1016/j.wjorl.2020.05.009https://doaj.org/article/1ad2bf9bea2a4486911d37633b76cb392021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881120300949https://doaj.org/toc/2095-8811Objective: Salivary gland tumors account for 6%–8% of head and neck neoplasms with the parotid gland as the most common primary site. Pleomorphic adenomas (PA) are considered the most common benign parotid gland neoplasms, followed by Warthin tumors (WT). The goal of this study was to investigate the distribution of parotid gland neoplasms among a United States veteran population. Design: Retrospective chart review. Setting: Washington DC Veterans Affairs Medical Center. Participants: Veterans who underwent fine needle aspiration (FNA) for a parotid gland mass from 2000 to 2018 were included. Medical records were reviewed for gender, age, tobacco use, surgery date, and pathology results. Main outcome measures: Changes in the distribution of parotid neoplasms and tobacco use over an 18-year period. Results: Of 141 patients with parotid gland masses, 86.5% (n = 122) were benign, 9.9% (n = 14) were malignant, and 3.5% (n = 5) were indeterminate. Of benign tumors, WT accounted for the majority at 51.6%, followed by PA at 40.2%. When stratified by decade (2000–2009 and 2010–2018), the proportion of WT compared to all other benign and malignant neoplasms increased from 31.6% to 53.6%, whereas the proportion of PA decreased from 36.8% to 33.3%. The rate of tobacco use was unchanged at approximately 32.0% among our cohort from 2000 to 2018. Conclusion: Among our cohort of veteran patients, WT was the most common benign parotid tumor and has increased in incidence over the last two decades despite an unchanged smoking rate.Adnan S. HussainiNavin R. PrasadEdina PaalEshetu A. TeferaSonya MalekzadehJessica H. MaxwellKeAi Communications Co., Ltd.articleParotid neoplasmWarthin tumorPleomorphic adenomaTobaccoHead and neck cancerVeteranOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 7, Iss 4, Pp 285-290 (2021)
institution DOAJ
collection DOAJ
language EN
topic Parotid neoplasm
Warthin tumor
Pleomorphic adenoma
Tobacco
Head and neck cancer
Veteran
Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Parotid neoplasm
Warthin tumor
Pleomorphic adenoma
Tobacco
Head and neck cancer
Veteran
Otorhinolaryngology
RF1-547
Surgery
RD1-811
Adnan S. Hussaini
Navin R. Prasad
Edina Paal
Eshetu A. Tefera
Sonya Malekzadeh
Jessica H. Maxwell
The distribution of parotid gland neoplasms in a veteran population
description Objective: Salivary gland tumors account for 6%–8% of head and neck neoplasms with the parotid gland as the most common primary site. Pleomorphic adenomas (PA) are considered the most common benign parotid gland neoplasms, followed by Warthin tumors (WT). The goal of this study was to investigate the distribution of parotid gland neoplasms among a United States veteran population. Design: Retrospective chart review. Setting: Washington DC Veterans Affairs Medical Center. Participants: Veterans who underwent fine needle aspiration (FNA) for a parotid gland mass from 2000 to 2018 were included. Medical records were reviewed for gender, age, tobacco use, surgery date, and pathology results. Main outcome measures: Changes in the distribution of parotid neoplasms and tobacco use over an 18-year period. Results: Of 141 patients with parotid gland masses, 86.5% (n = 122) were benign, 9.9% (n = 14) were malignant, and 3.5% (n = 5) were indeterminate. Of benign tumors, WT accounted for the majority at 51.6%, followed by PA at 40.2%. When stratified by decade (2000–2009 and 2010–2018), the proportion of WT compared to all other benign and malignant neoplasms increased from 31.6% to 53.6%, whereas the proportion of PA decreased from 36.8% to 33.3%. The rate of tobacco use was unchanged at approximately 32.0% among our cohort from 2000 to 2018. Conclusion: Among our cohort of veteran patients, WT was the most common benign parotid tumor and has increased in incidence over the last two decades despite an unchanged smoking rate.
format article
author Adnan S. Hussaini
Navin R. Prasad
Edina Paal
Eshetu A. Tefera
Sonya Malekzadeh
Jessica H. Maxwell
author_facet Adnan S. Hussaini
Navin R. Prasad
Edina Paal
Eshetu A. Tefera
Sonya Malekzadeh
Jessica H. Maxwell
author_sort Adnan S. Hussaini
title The distribution of parotid gland neoplasms in a veteran population
title_short The distribution of parotid gland neoplasms in a veteran population
title_full The distribution of parotid gland neoplasms in a veteran population
title_fullStr The distribution of parotid gland neoplasms in a veteran population
title_full_unstemmed The distribution of parotid gland neoplasms in a veteran population
title_sort distribution of parotid gland neoplasms in a veteran population
publisher KeAi Communications Co., Ltd.
publishDate 2021
url https://doaj.org/article/1ad2bf9bea2a4486911d37633b76cb39
work_keys_str_mv AT adnanshussaini thedistributionofparotidglandneoplasmsinaveteranpopulation
AT navinrprasad thedistributionofparotidglandneoplasmsinaveteranpopulation
AT edinapaal thedistributionofparotidglandneoplasmsinaveteranpopulation
AT eshetuatefera thedistributionofparotidglandneoplasmsinaveteranpopulation
AT sonyamalekzadeh thedistributionofparotidglandneoplasmsinaveteranpopulation
AT jessicahmaxwell thedistributionofparotidglandneoplasmsinaveteranpopulation
AT adnanshussaini distributionofparotidglandneoplasmsinaveteranpopulation
AT navinrprasad distributionofparotidglandneoplasmsinaveteranpopulation
AT edinapaal distributionofparotidglandneoplasmsinaveteranpopulation
AT eshetuatefera distributionofparotidglandneoplasmsinaveteranpopulation
AT sonyamalekzadeh distributionofparotidglandneoplasmsinaveteranpopulation
AT jessicahmaxwell distributionofparotidglandneoplasmsinaveteranpopulation
_version_ 1718377313003896832